Company / Return on Assets (ROA)
CG Oncology, Inc. Return on Assets (ROA) History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-20.3%
FY2025
5-year range
-24.4% / -11.7%
FY2023-FY2025
Trend
-74.4%
vs FY2024
Sector context
#101 of 213
Health Care
What the data says
At -20.3%, CG Oncology, Inc.'s return on assets (roa) ranks #101 of 213 in the Health Care sector. Improved from -24.4% to -20.3% over the past 2 years.
Based on SEC 10-K filings.
-20.3% in FY2025.
Improved from -24.4% to -20.3% over the past 2 years.
Health Care sector context is included.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
#101 of 213 in Health CareTop 47% of 213This company -20.3% Sector average -24.1%
▼
+15.7% above sector average
Key checks
Key Insights
- In FY2025, return on assets (roa) decreased 74.4% year-over-year.
- Currently 3.8pp above the Health Care sector average.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 8.02 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -20.3% | -74.4% |
| FY2024 | -11.7% | +52.2% |
| FY2023 | -24.4% | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026